Trial Profile
Bridging Study: A Phase 2 Study Investigating Clofarabine, Cyclophosphamide and Etoposide for Children, Adolescents, and Young Adults (AYA) With Acute Leukemia and Minimal Residual Disease
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2019
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cyclophosphamide (Primary) ; Etoposide (Primary)
- Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 05 May 2017 Status changed from recruiting to discontinued.
- 05 Feb 2015 New trial record